Free Trial

TNF Pharmaceuticals (TNFA) Competitors

TNF Pharmaceuticals logo
$0.06 -0.01 (-16.78%)
Closing price 04:00 PM Eastern
Extended Trading
$0.07 +0.01 (+10.24%)
As of 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TNFA vs. HCWB, KTTA, THAR, VYNE, BCTX, AEZS, SPRB, TTNP, CPHI, and REVB

Should you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include HCW Biologics (HCWB), Pasithea Therapeutics (KTTA), Tharimmune (THAR), VYNE Therapeutics (VYNE), Briacell Therap (BCTX), Aeterna Zentaris (AEZS), Spruce Biosciences (SPRB), Titan Pharmaceuticals (TTNP), China Pharma (CPHI), and Revelation Biosciences (REVB). These companies are all part of the "pharmaceutical products" industry.

TNF Pharmaceuticals vs. Its Competitors

TNF Pharmaceuticals (NASDAQ:TNFA) and HCW Biologics (NASDAQ:HCWB) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability.

TNF Pharmaceuticals has higher earnings, but lower revenue than HCW Biologics. HCW Biologics is trading at a lower price-to-earnings ratio than TNF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TNF PharmaceuticalsN/AN/A-$23.36M-$2.31-0.03
HCW Biologics$2.57M1.93-$30.02M-$14.04-0.25

HCW Biologics has a consensus price target of $35.00, indicating a potential upside of 914.49%. Given HCW Biologics' stronger consensus rating and higher possible upside, analysts plainly believe HCW Biologics is more favorable than TNF Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TNF Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
HCW Biologics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, HCW Biologics had 4 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 7 mentions for HCW Biologics and 3 mentions for TNF Pharmaceuticals. TNF Pharmaceuticals' average media sentiment score of 0.78 beat HCW Biologics' score of -0.27 indicating that TNF Pharmaceuticals is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TNF Pharmaceuticals
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
HCW Biologics
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

TNF Pharmaceuticals has a beta of 1.82, suggesting that its share price is 82% more volatile than the S&P 500. Comparatively, HCW Biologics has a beta of 0.66, suggesting that its share price is 34% less volatile than the S&P 500.

TNF Pharmaceuticals has a net margin of 0.00% compared to HCW Biologics' net margin of -1,368.55%. HCW Biologics' return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
TNF PharmaceuticalsN/A -69.21% -33.98%
HCW Biologics -1,368.55%N/A -40.72%

9.6% of TNF Pharmaceuticals shares are owned by institutional investors. Comparatively, 3.0% of HCW Biologics shares are owned by institutional investors. 0.5% of TNF Pharmaceuticals shares are owned by company insiders. Comparatively, 42.7% of HCW Biologics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

TNF Pharmaceuticals beats HCW Biologics on 8 of the 15 factors compared between the two stocks.

Get TNF Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TNFA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TNFA vs. The Competition

MetricTNF PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$886K$2.80B$5.82B$9.74B
Dividend YieldN/A1.66%3.84%4.09%
P/E Ratio-0.0322.6131.1525.97
Price / SalesN/A751.86475.57123.18
Price / CashN/A173.2237.1558.38
Price / Book0.175.869.116.39
Net Income-$23.36M$31.83M$3.26B$265.66M
7 Day PerformanceN/A1.80%2.11%1.98%
1 Month PerformanceN/A4.36%5.12%1.33%
1 Year PerformanceN/A11.44%31.25%21.15%

TNF Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TNFA
TNF Pharmaceuticals
N/A$0.06
-16.8%
N/AN/A$886KN/A-0.036Earnings Report
Gap Down
High Trading Volume
HCWB
HCW Biologics
2.1845 of 5 stars
$3.83
-6.4%
$35.00
+814.1%
-80.7%$5.49M$2.57M-0.1640Earnings Report
Short Interest ↑
KTTA
Pasithea Therapeutics
1.2416 of 5 stars
$0.73
+2.0%
N/A-85.1%$5.39MN/A-0.103Positive News
Short Interest ↓
THAR
Tharimmune
3.3622 of 5 stars
$1.26
-3.1%
$17.00
+1,249.2%
+74.4%$5.32MN/A-0.212News Coverage
Gap Down
VYNE
VYNE Therapeutics
2.2175 of 5 stars
$0.35
+1.2%
$6.25
+1,696.0%
-82.7%$5.29M$500K-0.3930
BCTX
Briacell Therap
2.9453 of 5 stars
$0.77
+1.0%
$32.00
+4,050.5%
-94.2%$5.14MN/A-0.098News Coverage
AEZS
Aeterna Zentaris
N/A$2.85
-18.6%
N/A-52.6%$5.11M$2.37M-0.1920High Trading Volume
SPRB
Spruce Biosciences
2.1582 of 5 stars
$9.01
+3.0%
$131.25
+1,356.7%
-76.7%$5.06M$4.91M-9.5920Gap Up
TTNP
Titan Pharmaceuticals
0.3168 of 5 stars
$5.34
+8.2%
N/A-40.0%$4.72M$180K-1.7610
CPHI
China Pharma
0.9256 of 5 stars
$1.44
+1.0%
N/A-92.7%$4.71M$4.30M0.00250Gap Up
REVB
Revelation Biosciences
0.166 of 5 stars
$2.77
+2.2%
N/A-97.5%$4.71MN/A-0.0410Short Interest ↑
Gap Up

Related Companies and Tools


This page (NASDAQ:TNFA) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners